Literature DB >> 25626343

OPTN/SRTR 2013 Annual Data Report: pancreas.

R Kandaswamy1, M A Skeans, S K Gustafson, R J Carrico, K H Tyler, A K Israni, J J Snyder, B L Kasiske.   

Abstract

Pancreas listings and transplants decreased during the past decade, most notably pancreas after kidney transplants. Center-reported outcomes of pancreas transplant across all groups, short-term and long-term, improved during the same period. Changes to the pancreas allocation system creating an efficient, uniform national system will be implemented in late 2014. Pancreas-alone and simultaneous pancreas-kidney (SPK) candidates will form a single match-run list with priority to most SPK candidates ahead of kidney-alone candidates to decrease waiting times for SPK candidates, given their higher waitlist mortality compared with nondiabetic kidney transplant candidates. The changes are expected to eliminate local variability, providing more consistent pancreas allocation nationwide. Outcomes after pancreas transplant are challenging to interpret due to lack of a uniform definition of graft failure. Consequently, SRTR has not published data on pancreas graft failure for the past 2 years. The Organ Procurement and Transplantation Network Pancreas Transplantation Committee is working on a definition that could provide greater validity for future outcomes analyses. Challenges in pancreas transplantation include high risk of technical failures, rejection (early and late), and surgical complications. Continued outcome improvement and innovation has never been more critical, as alternatives such as islet transplant and artificial pancreas move closer to clinical application. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Pancreas after kidney transplant; pancreas allocation policy; pancreas transplant alone; simultaneous pancreas-kidney transplant

Mesh:

Year:  2015        PMID: 25626343     DOI: 10.1111/ajt.13196

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

Authors:  C M Lin; R J Plenter; M Coulombe; R G Gill
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

Review 2.  Exocrine drainage in vascularized pancreas transplantation in the new millennium.

Authors:  Hany El-Hennawy; Robert J Stratta; Fowler Smith
Journal:  World J Transplant       Date:  2016-06-24

3.  Pancreas-After-Islet Transplantation in Nonuremic Type 1 Diabetes: A Strategy for Restoring Durable Insulin Independence.

Authors:  S A Wisel; J M Gardner; G R Roll; J Harbell; C E Freise; S Feng; S M Kang; R Hirose; D B Kaufman; A M Posselt; P G Stock
Journal:  Am J Transplant       Date:  2017-06-06       Impact factor: 8.086

Review 4.  Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.

Authors:  S D Sackett; M E Brown; D M Tremmel; T Ellis; W J Burlingham; J S Odorico
Journal:  Transplant Rev (Orlando)       Date:  2016-02-10       Impact factor: 3.943

Review 5.  Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy.

Authors:  Janaina Paulini; Eliza Higuti; Rosana M C Bastos; Samirah A Gomes; Érika B Rangel
Journal:  Stem Cells Int       Date:  2016-12-13       Impact factor: 5.443

6.  Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients.

Authors:  Jonna R Bank; Sebastiaan Heidt; Dirk Jan A R Moes; Dave L Roelen; Marko J K Mallat; Paul J M van der Boog; Manon Vergunst; Cornelia M Jol-van der Zijde; Robbert G M Bredius; Andries E Braat; Jan Ringers; Maarten J D van Tol; Frans H J Claas; Marlies E J Reinders; Johannes W de Fijter
Journal:  Transplant Direct       Date:  2016-12-19

7.  Association between the pancreas transplantation and survival of patients with diabetes: A single center experience.

Authors:  Ji Yoon Choi; Joo Hee Jung; Sung Shin; Young Hoon Kim; Duck Jong Han
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 8.  Regenerative Medicine and Diabetes: Targeting the Extracellular Matrix Beyond the Stem Cell Approach and Encapsulation Technology.

Authors:  Andrea Peloso; Antonio Citro; Tamara Zoro; Lorenzo Cobianchi; Arianna Kahler-Quesada; Carlo M Bianchi; Axel Andres; Ekaterine Berishvili; Lorenzo Piemonti; Thierry Berney; Christian Toso; Graziano Oldani
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-31       Impact factor: 5.555

Review 9.  Kidney Transplantation in the Diabetic Patient.

Authors:  María José Pérez-Sáez; Julio Pascual
Journal:  J Clin Med       Date:  2015-06-09       Impact factor: 4.241

10.  Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas.

Authors:  Sara Dutton Sackett; Daniel M Tremmel; Fengfei Ma; Austin K Feeney; Rachel M Maguire; Matthew E Brown; Ying Zhou; Xiang Li; Cori O'Brien; Lingjun Li; William J Burlingham; Jon S Odorico
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.